Well-characterized biospecimens assist development of cancer immunotherapies
AMSBIO (Oxford, UK) reports how its biospecimens were used in a large-scale immuno-oncology study analyzing fibroblast activation protein (FAP) expression across 23 tumor types, contributing to new…
Read the full articleYou might also wanna read
Genome-wide variation in cell-free DNA end-motif entropy predicts immunotherapy response in head and neck cancer
BACKGROUND Minimally invasive biomarkers predicting the immunotherapy response in head and neck squamous cell carcinoma (HNSCC) remain an un
Explainable machine learning-guided integrated multiomics analysis reveals macrophage-driven immune suppression in breast cancer
Discoveries in breast cancer show macrophages drive immune suppression; new machine learning model links TME cellular makeup to relapse-free
Científicos financiados por los Institutos Nacionales de la Salud descubren pistas sobre las lesiones precancerosas y la biología tumoral
En nuevos estudios publicados por la Red del Atlas de Tumores Humanos (HTAN) del Instituto Nacional del Cáncer (NCI), se explora la función
CancerVax Develops Novel Smart mRNA to Harness Pre-Existing Immunity in 99% of World Population
Company completes design and in-vitro validation of a single Smart mRNA that disguises cancer as multiple viral infections simultaneously to
Proteomic and phosphoproteomic profiling reveals melanoma cell responses to T cell attack
Franciosa et al. map the complex protein signaling between patient-derived melanoma and autologous T cells during active tumor attack. By an
14-protein plasma signature predicts lung cancer risk years before diagnosis and identifies candidates for preventive therapy
A 14-protein plasma signature identifies individuals benefiting from anti-IL-1β-based lung cancer risk reduction and demonstrates how divers
Comments
Sign in to join the conversation.
No comments yet. Be the first.